Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748122 · ClinicalTrials.gov registry record · NA
CSII Pilot in Adolescents With Type 2 Diabetes
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02748122: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT02748122 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748122, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This feasibility pilot is intended to understand whether adolescents with Type 2 Diabetes (2DM) can be transitioned to a continuous subcutaneous insulin injection (CSII) and if so, assess whether CSII is a feasible treatment modality and improves quality of life (QOL) in adolescents with T2DM over 3 month period.
Interventions
- OTHER MMT 723
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-03-27 |
| Phase | NA |
Why NCT02748122 stopped before completion
NCT02748122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which MMT 723 is the first listed.
NCT02748122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02748122 about?
NCT02748122 is a clinical study titled "CSII Pilot in Adolescents With Type 2 Diabetes". This feasibility pilot is intended to understand whether adolescents with Type 2 Diabetes (2DM) can be transitioned to a continuous subcutaneous insulin injection (CSII) and if so, assess whether CSII is a feasible treatment modality and improves quality of life (QOL) in adolescents with T2DM over 3...
What is the current status of trial NCT02748122?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2015-10. Estimated completion is 2019-03-27.
What interventions are being tested in trial NCT02748122?
The interventions under investigation include: MMT 723 (OTHER).
Who is sponsoring clinical trial NCT02748122?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02748122's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia